Canada needs pharmacare now
Delays continue to threaten Bill C-64’s passage, leaving millions of Canadians without the prescription coverage they urgently need.
Cannabis industry seeks change as part of profits go up in smoke under outdated tax regime: stakeholders
Switching to a flat-rate tax or a standardized excise stamp would help the industry ‘overnight,’ according to the Cannabis Council of Canada’s Paul McCarthy.
Contraception and family planning are vital for people and the planet
It is essential to integrate population dynamics and family planning into environmental and climate discussions, policies, and funding frameworks.
Ontario’s health-care system is putting Métis lives at risk—it’s time governments invest in research to influence meaningful change
Public policymakers and researchers need timely information that reflects the health-care needs of the Métis population.
Policy action is critical as Canada recognizes FASD Awareness Month
Advocates, medical experts, and those with lived experiences have for decades been calling on the federal government to take a leadership role.
Biotech
Canada needs to catch up in the biotech sector
Currently, our scientists have to look outside of the country to take their work to the next level, which means that Canada is not benefitting fully from Canadian ideas.
Unlocking Canada’s greatest economic potential: life sciences
The time has come for us to commit to life sciences as a driver for Canada’s economy with the knowledge that this sector can help solve some of our biggest societal challenges.
Canada’s biotech carpe diem
It’s imperative Canada keep pace with other competing jurisdictions, and establish itself as a regulatory leader that rewards investment and talent.
Harnessing the power of Canada’s growing biotechnology industry: a perspective from the West
Government investment and policy can help ensure groundbreaking technologies remain in Canada when companies scale up their production especially for international distribution.
